PMID: 16509022Mar 3, 2006Paper

Urban-rural differences in survival from cutaneous melanoma in Queensland

Australian and New Zealand Journal of Public Health
Michael CooryIan Ring

Abstract

To assess how much of the urban-rural disparity in melanoma survival in Queensland is due to later diagnosis. Data were obtained from the population-based Queensland Cancer Registry. We used incident cases for the six years 1996 to 2001 with follow-up to the end of 2002, so that all patients were followed for at least 12 months with a median follow-up time of 41 months. Cox regression models were used to compare urban versus rural case-fatality rates, after adjusting for thickness, level, subsite, age and sex. The adjusted case-fatality rate was 20% higher in rural versus urban areas (hazard ratio 1.20, 95% CI 1.02-1.43). There is some characteristic of living in an urban area, other than earlier diagnosis, that improves melanoma survival. In the first instance, differences in access to services and variation in management practices deserve investigation and exclusion.

References

May 1, 1994·The Journal of Dermatology·C BartoliN Cascinelli
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchA Morabito
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchJ F Thompson
Jan 18, 2002·Journal of Urban Health : Bulletin of the New York Academy of Medicine·UNKNOWN New York City Department of Health HIV Epidemiology Group
Feb 14, 2002·The British Journal of Dermatology·D L L RobertsUNKNOWN Melanoma Study Group
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marko B Lens, Martin Dawes
Sep 7, 2002·Cancer·John W GamelHilliard F Seigler
Jan 22, 2003·Internal Medicine Journal·P Hersey
Jan 22, 2003·The Cochrane Database of Systematic Reviews·J P Neilson
Jan 30, 2004·Salud pública de México·Silvina ArrossiDonald Maxwell Parkin
Jun 18, 2004·The Medical Journal of Australia·Katharine E JongBruce K Armstrong
Sep 3, 2004·The New England Journal of Medicine·Hensin TsaoArthur J Sober
Feb 3, 2005·Journal of the National Cancer Institute·Marianne BerwickRaymond Barnhill
Aug 4, 2005·Journal of the National Cancer Institute·Robert P DellavalleKathryn R Johnson

❮ Previous
Next ❯

Citations

Jul 21, 2007·Cancer Causes & Control : CCC·Monika JandaRachel Neale
May 13, 2008·The Australian Journal of Rural Health·Mitch J DuncanRyan L Kift
Nov 26, 2009·The Australian Journal of Rural Health·Craig UnderhillPaul Grogan
May 2, 2012·Journal of Skin Cancer·Marcelo MorenoVanessa Gheno
Jul 1, 2008·Biomedical Imaging and Intervention Journal·Es KohMb Barton
Apr 1, 2014·TheScientificWorldJournal·Chia-Chen HsuYueh-Ching Chou
Aug 24, 2013·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Joanna GreenAmanda J Lee
Feb 24, 2011·International Journal of Cancer. Journal International Du Cancer·Peter BaadePhilippa Youl
Jul 18, 2009·International Journal of Cancer. Journal International Du Cancer·Joanne F AitkenDallas English
Feb 7, 2006·Cancer Detection and Prevention·Philippa H YoulJoanne F Aitken
Feb 1, 2015·BMC Cancer·Peter D BaadeJoanne F Aitken
Oct 7, 2016·Journal of the American Academy of Dermatology·Alicia BrunssenAlexander Katalinic
Jun 20, 2018·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Peter MurchieAmanda J Lee
Jul 13, 2007·Melanoma Research·Peter D BaadeJoanne F Aitken
Mar 7, 2008·Cancer Causes & Control : CCC·Vanessa L BeesleyDiana Battistutta
Apr 4, 2017·Australian and New Zealand Journal of Public Health·Lena A von SchuckmannAdele C Green
Sep 27, 2018·Journal of Medical Internet Research·Audrey RollinAndrew Campbell
Jul 28, 2019·The Australian Journal of Rural Health·Scott KitchenerMatthew Masel
Jun 19, 2018·Frontiers in Medicine·Jenna E RaynerH Peter Soyer
Aug 14, 2020·Journal of the American Academy of Dermatology·Jose L CortezMaria L Wei
Aug 8, 2021·Journal of the American Academy of Dermatology·Bernice Y YanAmit Garg
Nov 4, 2021·JAMA Dermatology·Caroline G WattsAnne E Cust

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.